Arbutus Biopharma Corp. (ABUS)
4.53
-0.17
(-3.62%)
USD |
NASDAQ |
Mar 06, 16:00
4.49
-0.04
(-0.88%)
After-Hours: 20:00
Arbutus Biopharma EPS Diluted (Quarterly) : -0.0404 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Moderna, Inc. | -2.107 |
| Merck & Co., Inc. | 1.191 |
| Pfizer Inc. | -0.2898 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.742M |
| Revenue (Quarterly) | 0.529M |
| Total Expenses (Quarterly) | 8.271M |
| Enterprise Value | 782.13M |
| Gross Profit Margin (Quarterly) | 97.92% |
| Profit Margin (Quarterly) | -1.46K% |
| Earnings Yield | -4.90% |
| Normalized Earnings Yield | -3.645 |